Estimated antiretroviral therapy coverage among people living with HIV in Mauritania
Mauritania: Estimated antiretroviral therapy coverage among people living with HIV was 81.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Mauritania, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among people living with hiv in Mauritania is 81.0%, measured in 2025. That is the highest value across all 26 years on record.
The figure is up 3.8% on the previous year and up 92.9% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Mauritania peaked at 81.0% in 2025 and was at its lowest, 0.0%, in 2000.
That places Mauritania 49th out of 143 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Mauritania, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 5.0% | +400.0% |
| 2006 | 9.0% | +80.0% |
| 2007 | 14.0% | +55.6% |
| 2008 | 19.0% | +35.7% |
| 2009 | 24.0% | +26.3% |
| 2010 | 27.0% | +12.5% |
| 2011 | 29.0% | +7.4% |
| 2012 | 30.0% | +3.4% |
| 2013 | 36.0% | +20.0% |
| 2014 | 38.0% | +5.6% |
| 2015 | 42.0% | +10.5% |
| 2016 | 45.0% | +7.1% |
| 2017 | 52.0% | +15.6% |
| 2018 | 53.0% | +1.9% |
| 2019 | 58.0% | +9.4% |
| 2020 | 60.0% | +3.4% |
| 2021 | 64.0% | +6.7% |
| 2022 | 66.0% | +3.1% |
| 2023 | 73.0% | +10.6% |
| 2024 | 78.0% | +6.8% |
| 2025 | 81.0% | +3.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 7.2% | 0.0% | 24.0% | 10 |
| 2010s | 41.0% | 27.0% | 58.0% | 10 |
| 2020s | 70.3% | 60.0% | 81.0% | 6 |
Countries ranked near Mauritania
- 49 South Africa 81.0% compare
- 49 Azerbaijan 81.0% compare
- 49 Uruguay 81.0% compare
- 49 United Arab Emirates 81.0% compare
More health data for Mauritania
- Un projection of annual infant deaths, annual growth rate -0.8878 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.19 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 653 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,563 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.077 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Mauritania?
- Estimated antiretroviral therapy coverage among people living with hiv in Mauritania was 81.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Mauritania?
- The highest recorded value was 81.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Mauritania?
- The lowest recorded value was 0.0% in 2000.
- How does Mauritania rank for estimated antiretroviral therapy coverage among people living with hiv?
- Mauritania ranks 49th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Mauritania?
- Over the last ten years it is up 92.9%. The long-run trend across the full record is volatile.
- Where does this Mauritania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).